These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2651321)

  • 1. Role of cytokines and platelet-activating factor in microvascular immune injury.
    Braquet P; Hosford D; Braquet M; Bourgain R; Bussolino F
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):88-100. PubMed ID: 2651321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF, cytokines, toxic oxygen products and cell injury.
    Ward PA; Warren JS; Varani J; Johnson KJ
    Mol Aspects Med; 1991; 12(2):169-74. PubMed ID: 2072825
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion.
    Morland CM; Wilson SJ; Holgate ST; Roche WR
    Am J Respir Cell Mol Biol; 1992 May; 6(5):557-66. PubMed ID: 1316135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of tumour necrosis factor and other cytokines in immune-mediated vascular pathology.
    Grau GE; Piguet PF; Vassalli P; Lambert PH
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):34-9. PubMed ID: 2651318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent.
    Walsh GM; Mermod JJ; Hartnell A; Kay AB; Wardlaw AJ
    J Immunol; 1991 May; 146(10):3419-23. PubMed ID: 1709195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H2O2 release by adherent neutrophil leukocytes.
    von Asmuth EJ; Buurman WA
    J Immunol; 1995 Feb; 154(3):1383-90. PubMed ID: 7529802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of PAF and cytokines in microvascular tissue injury.
    Koltai M; Hosford D; Braquet P
    J Lab Clin Med; 1992 May; 119(5):461-6. PubMed ID: 1316420
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of cytokines and platelet-activating factor in renal pathology.
    Camussi G; Tetta C; Bussolino F; Andres G; Turello E; Baglioni C
    J Lipid Mediat; 1990; 2 Suppl():S203-13. PubMed ID: 2133283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection.
    Braquet P; Paubert-Braquet M; Bourgain RH; Bussolino F; Hosford D
    J Lipid Mediat; 1989; 1(2):75-112. PubMed ID: 2519889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell platelet-activating factor primes neutrophil responses: amplification of endothelial activation by neutrophil products.
    Vercellotti GM; Moldow CF; Wickham NW; Jacob HS
    J Lipid Mediat; 1990; 2 Suppl():S23-30. PubMed ID: 1966817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB; Erger RA; Little MM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Shock mediators and their antagonists as future therapeutic perspectives].
    Lundsgaard-Hansen P; Blauhut B; Doran JE
    Anaesthesiol Reanim; 1988; 13(3):123-40. PubMed ID: 3145751
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.
    Zimmerman GA; McIntyre TM; Mehra M; Prescott SM
    J Cell Biol; 1990 Feb; 110(2):529-40. PubMed ID: 2153685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion.
    Souza DG; Teixeira MM
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():59-66. PubMed ID: 15962100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune regulation by platelet-activating factor: II. Mediation of suppression by cytokine-stimulated endothelial cells in vitro.
    Lacasse C; Rola-Pleszczynski M
    J Leukoc Biol; 1991 Mar; 49(3):245-52. PubMed ID: 1997631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor.
    Sica A; Wang JM; Colotta F; Dejana E; Mantovani A; Oppenheim JJ; Larsen CG; Zachariae CO; Matsushima K
    J Immunol; 1990 Apr; 144(8):3034-8. PubMed ID: 2182712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis.
    Drost EM; MacNee W
    Eur J Immunol; 2002 Feb; 32(2):393-403. PubMed ID: 11813158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils.
    Chang SW
    Clin Res; 1992 Oct; 40(3):528-36. PubMed ID: 1395440
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy.
    Bussolino F; Biffignandi P; Arese P
    Acta Haematol; 1986; 75(3):129-40. PubMed ID: 3019063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation as an early component of atherosclerosis and vascular damage--a role for P-selectin and platelet-activating factor.
    Prescott SM; McIntyre TM; Zimmerman GA; Stafforini DM
    Jpn Circ J; 1996 Mar; 60(3):137-41. PubMed ID: 8741238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.